Giannini, E. G., & Trevisani, F. (2019). Ramucirumab as a second-line treatment for hepatocellular carcinoma: Reaching out further to patients with elevated alpha-fetoprotein. Hepatobiliary Surg Nutr.
Styl cytowania ChicagoGiannini, Edoardo G., i Franco Trevisani. "Ramucirumab As a Second-line Treatment for Hepatocellular Carcinoma: Reaching Out Further to Patients With Elevated Alpha-fetoprotein." Hepatobiliary Surg Nutr 2019.
Styl cytowania MLAGiannini, Edoardo G., i Franco Trevisani. "Ramucirumab As a Second-line Treatment for Hepatocellular Carcinoma: Reaching Out Further to Patients With Elevated Alpha-fetoprotein." Hepatobiliary Surg Nutr 2019.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..